These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33979039)

  • 1. A deep learning system to diagnose the malignant potential of urothelial carcinoma cells in cytology specimens.
    Nojima S; Terayama K; Shimoura S; Hijiki S; Nonomura N; Morii E; Okuno Y; Fujita K
    Cancer Cytopathol; 2021 Dec; 129(12):984-995. PubMed ID: 33979039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of an artificial intelligence algorithm for reporting urine cytopathology.
    Sanghvi AB; Allen EZ; Callenberg KM; Pantanowitz L
    Cancer Cytopathol; 2019 Oct; 127(10):658-666. PubMed ID: 31412169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Fully Automated Artificial Intelligence System to Assist Pathologists' Diagnosis to Predict Histologically High-grade Urothelial Carcinoma from Digitized Urine Cytology Slides Using Deep Learning.
    Tsuji K; Kaneko M; Harada Y; Fujihara A; Ueno K; Nakanishi M; Konishi E; Takamatsu T; Horiguchi G; Teramukai S; Ito-Ihara T; Ukimura O
    Eur Urol Oncol; 2024 Apr; 7(2):258-265. PubMed ID: 38065702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Deep Learning System to Predict the Histopathological Results From Urine Cytopathological Images.
    Liu Y; Jin S; Shen Q; Chang L; Fang S; Fan Y; Peng H; Yu W
    Front Oncol; 2022; 12():901586. PubMed ID: 35686096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a Machine Learning Algorithm for Identifying Abnormal Urothelial Cells: A Feasibility Study.
    Zhang Z; Fu X; Liu J; Huang Z; Liu N; Fang F; Rao J
    Acta Cytol; 2021; 65(4):335-341. PubMed ID: 33022673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of CK20 immunocytochemistry as an adjuvant to urine liquid-based cytology in detection of urothelial carcinoma].
    Li M; Li HX; Guo HQ; Zhao H; Zhao LL; Ma JH; Li CL; Cao J; Pan QJ
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):669-73. PubMed ID: 23159079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine cytology findings in patients with biopsy-confirmed urothelial carcinoma in situ with plasmacytoid features.
    Nichols MM; Reynolds JP; McKenney JK; Nicolas MM; McIntire PJ; Policarpio-Nicolas MLC
    Cancer Cytopathol; 2021 Oct; 129(10):798-804. PubMed ID: 33900681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of perioperative methylene blue-stained and permanent Papanicolaou-stained urine cytology to detect patients with high-grade urothelial cancer or the urinary bladder. Part 1].
    Rossi R; Jaeger T; Börgermann C; Furtkamp C; Moos Stahl R; Rübben H; vom Dorp F
    Urologe A; 2007 Sep; 46(9):1145-7. PubMed ID: 17661004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
    Sun T; Hutchinson L; Tomaszewicz K; Caporelli ML; Meng X; McCauley K; Fischer AH; Cosar EF; Cornejo KM
    Cancer Cytopathol; 2021 Jul; 129(7):537-547. PubMed ID: 33539671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the Paris Reporting System for Urine Cytology: The Three-Year Experience of a Single Tertiary Care Institute in Thailand.
    Phruttinarakorn B; Plumworasawat S; Kayankarnnavee J; Lualon J; Pongtippan A
    Acta Cytol; 2022; 66(2):134-141. PubMed ID: 34999581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma.
    Todenhöfer T; Hennenlotter J; Esser M; Mohrhardt S; Tews V; Aufderklamm S; Gakis G; Kuehs U; Stenzl A; Schwentner C
    Cancer Cytopathol; 2013 May; 121(5):252-60. PubMed ID: 23172833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial neural network in diagnosis of urothelial cell carcinoma in urine cytology.
    Muralidaran C; Dey P; Nijhawan R; Kakkar N
    Diagn Cytopathol; 2015 Jun; 43(6):443-9. PubMed ID: 25605418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reclassification of urinary cytology regarding The Paris System for Reporting Urinary Cytology with cytohistological correlation demonstrates high sensitivity for high-grade urothelial carcinoma.
    Anbardar MH; Monjazeb R
    Diagn Cytopathol; 2020 May; 48(5):446-452. PubMed ID: 31976626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16/Ki-67 dual labeling and urinary cytology results according to the New Paris System for Reporting Urinary Cytology: Impact of extended follow-up.
    Piaton E; Advenier AS; Carré C; Decaussin-Petrucci M; Mège-Lechevallier F; Hutin K; Nennig C; Colombel M; Ruffion A
    Cancer Cytopathol; 2017 Jul; 125(7):552-562. PubMed ID: 28371465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does subdivision of the "atypical" urine cytology increase predictive accuracy for urothelial carcinoma?
    Bostwick DG; Hossain D
    Diagn Cytopathol; 2014 Dec; 42(12):1034-44. PubMed ID: 24838797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
    Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
    Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of urine cytology in detecting histologic variants of urothelial carcinomas in the urinary bladder: Cytopathologic correlation of 72 cases.
    Yoo Y; Choi E; Lee DH; Park S; Sung SH
    Diagn Cytopathol; 2021 Mar; 49(3):367-373. PubMed ID: 33331144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the Paris system for reporting urinary cytology with histologic follow-up.
    Rohra P; Ocampo Gonzalez FA; Yan L; Mir F; Furlan K; Basu S; Barua A; Cheng L; Park JW
    Diagn Cytopathol; 2021 Jun; 49(6):691-699. PubMed ID: 33600080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma.
    Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N
    Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratin 17 Is a Novel Cytologic Biomarker for Urothelial Carcinoma Diagnosis.
    Babu S; Kim NW; Wu M; Chan I; Escobar-Hoyos LF; Shroyer KR
    Am J Clin Pathol; 2021 Oct; 156(5):926-933. PubMed ID: 34086841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.